(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are FuboTV, Beyond Meat, and Hecla Mining.

The three biggest losers today are Enzo Biochem, Castle Biosciences, and Palo Alto Networks.

Winners today

1. FuboTV (FUBO) – 16.28%

fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.

NYSE ended the session with FuboTV jumping 16.28% to $3.04 on Wednesday while NYSE rose 0.72% to $16,011.28.

Earnings Per Share

As for profitability, FuboTV has a trailing twelve months EPS of $-2.07.

Sales Growth

FuboTV’s sales growth is 36.2% for the ongoing quarter and 38.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuboTV’s stock is considered to be oversold (<=20).

More news about FuboTV.

2. Beyond Meat (BYND) – 13.71%

Beyond Meat, Inc. develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club, convenience, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.

NASDAQ ended the session with Beyond Meat jumping 13.71% to $17.58 on Wednesday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Beyond Meat has a trailing twelve months EPS of $-5.09.

More news about Beyond Meat.

3. Hecla Mining (HL) – 9.81%

Hecla Mining Company, together with its subsidiaries, provides precious and base metal properties in the United States and internationally. The company mines for silver, gold, lead, and zinc concentrates, as well as carbon material containing silver and gold for sale to custom smelters, metal traders, and third-party processors; and doré containing silver and gold. It owns 100% interests in the Greens Creek mine located on Admiralty Island in southeast Alaska; the Lucky Friday mine situated in northern Idaho; the Keno Hill mine located in the Keno Hill Silver District of Yukon Territory, Canada; the Casa Berardi mine located in the Abitibi region of northwestern Quebec, Canada; and the San Sebastian mine situated in the city of Durango, Mexico. The company was incorporated in 1891 and is headquartered in Coeur d'Alene, Idaho.

NYSE ended the session with Hecla Mining jumping 9.81% to $5.88 on Wednesday, following the last session’s downward trend. NYSE rose 0.72% to $16,011.28, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Hecla Mining has a trailing twelve months EPS of $-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.4%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7%, now sitting on 731.91M for the twelve trailing months.

Previous days news about Hecla Mining

• Hecla mining (hl) completes ATAC buy, resumes casa berardi. According to Zacks on Tuesday, 11 July, "Additionally, Hecla Mining invested CAD$2 million ($1.48 million) in seed capital, which is equal to a 19.9% interest, for a new exploration company Cascadia Minerals Ltd. ", "Shares of Hecla Mining have gained 43.9% in the past year, compared with the industry’s 0.7% growth."

More news about Hecla Mining.

4. First Majestic Silver (AG) – 9.02%

First Majestic Silver Corp. engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver and gold production in North America. Its projects include the San Dimas mine that consists of 119 individual concessions covering an area of 71,839 hectares located in Durango and Sinaloa States, México; the Santa Elena comprising 32 individual concessions that covers an area of 102,172 hectares located in Sonora State, México; and the La Encantada consists of 22 exploitation concessions covering an area of 4,076 hectares located in Coahuila State, México. The company was formerly known as First Majestic Resource Corp. and changed its name to First Majestic Silver Corp. in November 2006. First Majestic Silver Corp. was incorporated in 1979 and is headquartered in Vancouver, Canada.

NYSE ended the session with First Majestic Silver jumping 9.02% to $6.34 on Wednesday, after four consecutive sessions in a row of gains. NYSE rose 0.72% to $16,011.28, after three sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, First Majestic Silver has a trailing twelve months EPS of $-0.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.05%.

More news about First Majestic Silver.

5. Harmony Gold Mining Company Limited (HMY) – 8.7%

Harmony Gold Mining Company Limited engages in the exploration, extraction, and processing of gold. It also explores for uranium, silver, copper, and molybdenum deposits. The company has nine underground operations in the Witwatersrand Basin; an open-pit mine on the Kraaipan Greenstone Belt; and various surface treatment operations in South Africa. It also owns interests in the Hidden Valley, an open-pit gold and silver mine; and Wafi-Golpu, a project in Morobe Province in Papua New Guinea. The company was incorporated in 1950 and is headquartered in Randfontein, South Africa.

NYSE ended the session with Harmony Gold Mining Company Limited jumping 8.7% to $4.43 on Wednesday, after three successive sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after three sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Harmony Gold Mining Company Limited has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.72%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6%, now sitting on 43.95B for the twelve trailing months.

More news about Harmony Gold Mining Company Limited.

6. Ringcentral (RNG) – 8.64%

RingCentral, Inc. provides cloud communications, video meetings, collaboration, and contact center software-as-a-service solutions worldwide. The company's products include RingCentral Message Video Phone (MVP) that provides a unified experience for communication and collaboration across multiple modes, including HD voice, video, SMS, messaging and collaboration, conferencing, online meetings, and fax; RingCentral Contact Center, a collaborative contact center solution that delivers AI powered omni-channel and workforce engagement solution with integrated RingCentral MVP; and RingCentral Engage Digital, a digital customer engagement platform that allows enterprises to interact with their customers. The company's products also comprise RingCentral Engage Voice, a cloud-based outbound/blended customer engagement platform for midsize and enterprise companies; RingCentral Video, a video meeting service which includes the company's RCV video and team messaging capabilities and offers video and audio conferencing, file sharing, contact, task, and calendar management. In addition, it offers RingCentral professional services. The company serves a range of industries, including financial services, education, healthcare, legal services, real estate, retail, technology, insurance, construction, hospitality, and state and local government, as well as others. It sells its products through a network of direct sales representatives, as well as sales agents, resellers, and channel partners. The company was incorporated in 1999 and is headquartered in Belmont, California.

NYSE ended the session with Ringcentral jumping 8.64% to $38.15 on Wednesday, after four successive sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Ringcentral has a trailing twelve months EPS of $-8.53.

More news about Ringcentral.

7. LendingTree (TREE) – 8.53%

LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. In addition, the company offers QuoteWizard.com, a marketplace for insurance comparison; ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics from insurance to credit cards; and Stash, a consumer investing and banking platform that offers a suite of personal investment accounts, traditional and Roth IRAs, custodial investment accounts, and banking services, including checking accounts and debit cards with a Stock-Back rewards program. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is based in Charlotte, North Carolina.

NASDAQ ended the session with LendingTree rising 8.53% to $25.69 on Wednesday, following the last session’s upward trend. NASDAQ rose 1.15% to $13,918.96, after two successive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, LendingTree has a trailing twelve months EPS of $-12.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.24%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LendingTree’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.2%, now sitting on 902.32M for the twelve trailing months.

Volume

Today’s last reported volume for LendingTree is 300079 which is 5.14% below its average volume of 316339.

More news about LendingTree.

8. Bilibili (BILI) – 8.35%

Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, live broadcasting, and story mode. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

NASDAQ ended the session with Bilibili rising 8.35% to $16.80 on Wednesday, following the last session’s upward trend. NASDAQ rose 1.15% to $13,918.96, after two sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Bilibili has a trailing twelve months EPS of $-2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.59%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 49.3% and 62.1%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Bilibili’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Bilibili is 6044950 which is 24.4% above its average volume of 4858910.

More news about Bilibili.

9. StoneCo (STNE) – 8.21%

StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and sells solutions to brick-and-mortar and digital merchants through sales team. The company served approximately 2.6 million clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.

NASDAQ ended the session with StoneCo rising 8.21% to $12.32 on Wednesday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, StoneCo has a trailing twelve months EPS of $0.01.

PE Ratio

StoneCo has a trailing twelve months price to earnings ratio of 1232.5. Meaning, the purchaser of the share is investing $1232.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.09%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

StoneCo’s EBITDA is 3.29.

Moving Average

StoneCo’s value is below its 50-day moving average of $13.00 and way higher than its 200-day moving average of $10.79.

More news about StoneCo.

10. Express (EXPR) – 7.84%

Express, Inc. provides apparel and accessories for women and men for various occasions under the Express brand. The company sells its products through its e-commerce website, express.com; and mobile app, as well as franchisees Express locations in Latin America. As of January 29, 2022, it operated 561 stores in 46 states across the United States, as well as in Puerto Rico. The company was formerly known as Express Parent LLC and changed its name to Express, Inc. in May 2010. Express, Inc. was founded in 1980 and is headquartered in Columbus, Ohio.

NYSE ended the session with Express rising 7.84% to $0.70 on Wednesday, after three sequential sessions in a row of gains. NYSE rose 0.72% to $16,011.28, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Express has a trailing twelve months EPS of $3.63.

PE Ratio

Express has a trailing twelve months price to earnings ratio of 0.19. Meaning, the purchaser of the share is investing $0.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 206%.

Yearly Top and Bottom Value

Express’s stock is valued at $0.70 at 17:32 EST, way under its 52-week high of $2.70 and way higher than its 52-week low of $0.55.

More news about Express.

Losers Today

1. Enzo Biochem (ENZ) – -12.09%

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing ‘STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Farmingdale, New York.

NYSE ended the session with Enzo Biochem sliding 12.09% to $1.60 on Wednesday while NYSE jumped 0.72% to $16,011.28.

Earnings Per Share

As for profitability, Enzo Biochem has a trailing twelve months EPS of $-0.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.37%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 38.6%, now sitting on 71M for the twelve trailing months.

Yearly Top and Bottom Value

Enzo Biochem’s stock is valued at $1.60 at 17:32 EST, way under its 52-week high of $2.75 and way above its 52-week low of $1.00.

More news about Enzo Biochem.

2. Castle Biosciences (CSTL) – -10.06%

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary 35-GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

NASDAQ ended the session with Castle Biosciences sliding 10.06% to $17.70 on Wednesday while NASDAQ rose 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Castle Biosciences has a trailing twelve months EPS of $-2.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.33%.

More news about Castle Biosciences.

3. Palo Alto Networks (PANW) – -6.42%

Palo Alto Networks, Inc. provides cybersecurity solutions worldwide. The company offers firewall appliances and software; Panorama, a security management solution for the control of firewall appliances and software deployed on a customer's network, as well as their instances in public or private cloud environments, as a virtual or a physical appliance; and virtual system upgrades, which are available as extensions to the virtual system capacity that ships with physical appliances. It also provides subscription services covering the areas of threat prevention, malware and persistent threat, URL filtering, laptop and mobile device protection, and firewall; and DNS security, Internet of Things security, SaaS security API, and SaaS security inline, as well as threat intelligence, and data loss prevention. In addition, the company offers cloud security, secure access, security operations, and threat intelligence and cyber security consulting; professional services, including architecture design and planning, implementation, configuration, and firewall migration; education services, such as certifications, as well as online and in-classroom training; and support services. Palo Alto Networks, Inc. sells its products and services through its channel partners, as well as directly to medium to large enterprises, service providers, and government entities operating in various industries, including education, energy, financial services, government entities, healthcare, Internet and media, manufacturing, public sector, and telecommunications. The company was incorporated in 2005 and is headquartered in Santa Clara, California.

NYSE ended the session with Palo Alto Networks sliding 6.42% to $234.17 on Wednesday while NYSE jumped 0.72% to $16,011.28.

Earnings Per Share

As for profitability, Palo Alto Networks has a trailing twelve months EPS of $0.64.

PE Ratio

Palo Alto Networks has a trailing twelve months price to earnings ratio of 365.89. Meaning, the purchaser of the share is investing $365.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.43%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palo Alto Networks’s stock is considered to be overbought (>=80).

Volatility

Palo Alto Networks’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.06%, a positive 0.41%, and a positive 1.63%.

Palo Alto Networks’s highest amplitude of average volatility was 1.06% (last week), 1.46% (last month), and 1.63% (last quarter).

Moving Average

Palo Alto Networks’s worth is higher than its 50-day moving average of $216.05 and way above its 200-day moving average of $180.19.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.1%, now sitting on 6.49B for the twelve trailing months.

More news about Palo Alto Networks.

4. Zscaler (ZS) – -5.87%

Zscaler, Inc. operates as a cloud security company worldwide. It offers Zscaler Internet Access solution that provides users, workloads, IoT, and OT devices secure access to externally managed applications, including software-as-a-service (SaaS) applications and internet destinations; and Zscaler Private Access solution, which is designed to provide access to managed applications hosted internally in data centers, and private or public clouds. The company also provides Zscaler Digital Experience that measures end-to-end user experience across business applications, as well as provides an easy to understand digital experience score for each user, application, and location within an enterprise. In addition, it offers Posture Control solutions comprising Cloud Security Posture Management that identifies and remediates application misconfigurations in SaaS, infrastructure as a service, and PaaS to reduce risk and ensure compliance with industry and organizational benchmarks; Cloud Infrastructure Entitlement Management that detects and remediates excessive or unused cloud permissions and enforces least privileged access without disrupting productivity; Infrastructure as Code (IaC), which analyzes IaC templates to identify misconfigurations and other security issues prior to deployment to cloud infrastructure; and Vulnerability Scanning and Data Loss Prevention solutions. The company's platform modules include Zscaler Central Authority, Zscaler Enforcement Node, and Zscaler Log Servers. It serves customers in airlines and transportation, conglomerates, consumer goods and retail, financial services, healthcare, manufacturing, media and communications, public sector and education, technology, and telecommunications services industries. The company was formerly known as SafeChannel, Inc., and changed its name to Zscaler, Inc. in August 2008. Zscaler, Inc. was incorporated in 2007 and is headquartered in San Jose, California.

NASDAQ ended the session with Zscaler dropping 5.87% to $138.74 on Wednesday, following the last session’s downward trend. NASDAQ jumped 1.15% to $13,918.96, after two consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, Zscaler has a trailing twelve months EPS of $-2.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.55%.

Yearly Top and Bottom Value

Zscaler’s stock is valued at $138.74 at 17:32 EST, way under its 52-week high of $194.21 and way above its 52-week low of $84.93.

Sales Growth

Zscaler’s sales growth for the current quarter is 35.3%.

More news about Zscaler.

5. Cloudflare (NET) – -5.03%

CloudFlare, Inc. operates as a cloud services provider that delivers a range of services to businesses worldwide. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and IoT devices; and website and application security products comprising web application firewall, bot management, distributed denial of service, API gateways, SSL/TLS encryption, secure origin connection, and rate limiting products. It also offers website and application performance solutions, including content delivery, load balancing, DNS, agro smart routing, video stream delivery, content optimization, virtual backbone, always online, and cloudflare waiting room and registrar; and network services, which deliver network connectivity, security, and performance to customers as a service, including WAN, WARP, magic transit, magic firewall, cloudflare network interconnect, and spectrum. In addition, the company provides zero trust services, such as cloudflare access, cloudflare gateway, remote browser isolation, cloud access security broker, cloudflare area 1 email security, and data loss prevention products that protect, inspect, and privilege data. Further, it provides developer-based solutions consisting of cloudflare workers, pages, stream, and images, as well as Cloudflare Data Localization suite, a tool that set rules and controls at the network edge; durable objects and R2 object storage products; Consumer DNS Resolver, a consumer app to browse the Internet; and consumer VPN for consumers to secure and accelerate traffic on mobile devices. The company serves customers in the technology, healthcare, financial services, consumer and retail, and non-profit industries, as well as government. CloudFlare, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

NYSE ended the session with Cloudflare dropping 5.03% to $64.53 on Wednesday while NYSE rose 0.72% to $16,011.28.

Earnings Per Share

As for profitability, Cloudflare has a trailing twelve months EPS of $-0.58.

More news about Cloudflare.

6. Afya (AFYA) – -4.37%

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

NASDAQ ended the session with Afya sliding 4.37% to $14.88 on Wednesday, following the last session’s upward trend. NASDAQ rose 1.15% to $13,918.96, after two successive sessions in a row of gains, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Afya has a trailing twelve months EPS of $0.85.

PE Ratio

Afya has a trailing twelve months price to earnings ratio of 17.51. Meaning, the purchaser of the share is investing $17.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.71%.

More news about Afya.

7. Cigna (CI) – -4%

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

NYSE ended the session with Cigna falling 4% to $270.46 on Wednesday, after four sequential sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Cigna has a trailing twelve months EPS of $21.54.

PE Ratio

Cigna has a trailing twelve months price to earnings ratio of 12.56. Meaning, the purchaser of the share is investing $12.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.07%.

Volume

Today’s last reported volume for Cigna is 1694360 which is 0.71% above its average volume of 1682350.

Previous days news about Cigna

• Cigna (ci) to add three biosimilars to npf, enable cost savings. According to Zacks on Tuesday, 11 July, "The pharmacy benefits management ("PBM") unit of The Cigna Group’s (CI Quick QuoteCI – Free Report) Evernorth segment, Express Scripts, recently revealed plans to include three biosimilars within the preferred product list on its National Preferred Formulary ("NPF").", "Shares of Cigna have gained 6.8% in the past three months against the industry’s 11.2% decline. "

More news about Cigna.

8. Cigna (CI) – -4%

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

NYSE ended the session with Cigna sliding 4% to $270.46 on Wednesday, after four consecutive sessions in a row of gains. NYSE jumped 0.72% to $16,011.28, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Cigna has a trailing twelve months EPS of $21.54.

PE Ratio

Cigna has a trailing twelve months price to earnings ratio of 12.56. Meaning, the purchaser of the share is investing $12.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.07%.

Sales Growth

Cigna’s sales growth is 3.8% for the ongoing quarter and 6.5% for the next.

Previous days news about Cigna

• Cigna (ci) to add three biosimilars to npf, enable cost savings. According to Zacks on Tuesday, 11 July, "The pharmacy benefits management ("PBM") unit of The Cigna Group’s (CI Quick QuoteCI – Free Report) Evernorth segment, Express Scripts, recently revealed plans to include three biosimilars within the preferred product list on its National Preferred Formulary ("NPF").", "Shares of Cigna have gained 6.8% in the past three months against the industry’s 11.2% decline. "

More news about Cigna.

9. Xenetic Biosciences (XBIO) – -3.85%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences dropping 3.85% to $4.01 on Wednesday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-3.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.06%.

Sales Growth

Xenetic Biosciences’s sales growth is 5.5% for the ongoing quarter and 15.9% for the next.

More news about Xenetic Biosciences.

10. Viking Therapeutics (VKTX) – -3.78%

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Viking Therapeutics falling 3.78% to $15.40 on Wednesday while NASDAQ jumped 1.15% to $13,918.96.

Earnings Per Share

As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.96.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.71%.

More news about Viking Therapeutics.

Stay up to date with our winners and losers daily report